Management of Women with Clomiphene Citrate Resistant Polycystic Ovary Syndrome DR Seyed Mehdi Ahmadi OB & Gynecologist Isfahan Fertility & Infertility.

Slides:



Advertisements
Similar presentations
Ovulation Induction Dr Elsamawal El Hakim
Advertisements

PCOS and Fertility Positive Steps Forward
  LONG TERM WEIGHT MANAGEMENT TO PROMOTE REPRODUCTIVE HEALTH IN OVER WEIGHT/OBEASE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME.   DR.PREMA.H.S,
Elonva in poor responders
Polycystic Ovarian Syndrome
Management of the Commonest Endocrine disorder in females Miss Bini Ajay.
Infertility and PCOS Erinn Myers, M4 Department of Obstetrics and Gynecology University of Tennessee Health Science Center January 28, 2007.
Al- Jalla Maternity Hospital
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Infertility 101 Dana Ambler, DO Director, Donor Egg Program Associate Physician Conceptions Reproductive Associates.
DR. ZEINAB ABOTALIB Professor & Consultant Obstetrics & Gynecology Dept.
IN THE NAME OF GOD Elham Faghihimani endocrinologist.
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
G.Paavan. General management :  Reduce heat around the scrotum ----cold water baths, use of cotton/ loose underwear etc.  Avoidance of alcohol  Cessation.
© Copyright Annals of Internal Medicine, 2011 Ann Int Med. 154 (3): ITC2-1. Terms of Use  The In the Clinic ® slide sets are owned and copyrighted by.
The Effect of PCOS Treatment on Ovarian Function
SURGICAL TREATMENT OF PCOS SURGICAL TREATMENT OF PCOS Professor T C LI Professor of Reproductive Medicine & Surgery Sheffield.
PCOS Polycystic Ovary Syndrome
TEMPLATE DESIGN © Laparoscopic Ovarian Drilling For Polycystic Ovary Syndrome(PCOS) – Are We Wasting Women’s Time? Chima.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
INFERTILITY ASSOCIATED WITH PCOS Dr. Norlia Bahauddin Hospital Kajang.
Ovulation-Inducing Agent Presented by: Zinab Al-hajari.
Comparison Of Letrozole And Clomiphene Citrate Saima Ahmad MRCOG Riaz Medical Center Sharjah. UAE Objectives Conclusions Competing Interest References.
Basic Reproduction From
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Polycystic Ovary Syndrome Melissa McCarthy June 1, 2010.
HIRSUTISM. Definition  Hirsutism Excessive growth of hair in abnormal position on the body  Virilism Masculinization of female i.e. deepening of voice,
Polycystic Ovary Syndrome
Polycystic Ovary Syndrome Jamal Zaidi Consultant Obstetrician & Gynaecologist East Sussex Healthcare NHS Trust.
Shahla Chaichian Associate Professor of Ob& Gyn Fellowship of Gynecology Laparoscopy Deputy director of minimally invasive surgery research center of IUMS.
Treatment Options for Infertility
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Polycystic Ovarian Disorder Max Brinsmead MB BS PhD August 2014.
The Effects of Inositol on Women with Polycystic Ovary Syndrome(PCOS)
CONSENSUS ON INFERTILITY TREATMENT RELATED TO POLYCYSTIC OVARY SYNDROME Asc.Prof. Dr. Kazım GEZGİNÇ Konya University, Faculty of Meram Medicine, Department.
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Thiazolidinediones Inhibit Aromatase Activity in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase Takako Araki M.D. Dimiter Avtanski.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Polycystic ovarian syndrome Can lifestyle modifications help??
In women resistant to clomiphene citrate, or metformin combined with clomiphene, the next step has been gonadotropin therapy. While this treatment causes.
Please Be Sure You Have An Audience-Response Device (Clicker)
PCOS & EXERCISE Bob Tygenhof, MA, CPT Director, Center for Active Lifestyle Medicine Integrative Medical Group of Irvine.
Dr. ASMAA A. AL SANJARY. The student at the end of this lecture should be able to: Enumerate the diagnostic criteria for PCOS. Describe it’s clinical.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Polycystic ovary syndrome Dr. Raghad Abdul-Halim Al-Issa Polycystic ovary syndrome Dr. Raghad Abdul-Halim Al-Issa.
Role of decreased androgens in the ovarian response to stimulation in older women Fertil Steril Jan;99(1):5-11 Presented by Hsing-Chun Tsai
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
PCOS Dr. Mridula A Benjamin Dept of Obs and Gyn RIPAS Hospital, Brunei.
Hyperprolactinaemia. Introduction.  Prolactine (PRL) is secreted from the Anterior Hypophisis.  Normal blood level of PRL: IU/L or 12.5 – 25.
King Khalid University Hospital Department of Obstetrics & Gynecology
Polycystic ovarian syndrome
Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Disease
Laparoscopic electrocautery of the ovaries
Polycystic ovarian syndrome Obesity and Insulin resistance
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
Presentation transcript:

Management of Women with Clomiphene Citrate Resistant Polycystic Ovary Syndrome DR Seyed Mehdi Ahmadi OB & Gynecologist Isfahan Fertility & Infertility Center

Indications I. Ovulation induction: in the following cases: a) C.C resistant PCO: Defined as failure to ovulate on a dose of 100 mg, for 5 days (recently in 3 cycles, in contrast to 6 cycles in the past ) or failure to ovulate on incremental doses of CC(50-150mg). b) C.C failure PCO: Defined when pregnancy does not occur despite of regular ovulation on C.C for 6-9 cycles. c) C.C pregnancy failure: Defined as failure to maintain pregnancy conceived with C.C.

Increased Serine phosphorylation Decreased glucose transport Hyperinsulinemia P450c 17 &17,20 lyase activity Adrenals : Increased DHEAS Ovaries : Increased Androstenedione& testosterone

Various treatment modalities Tre Pharmacological CC ? Gonadotropin Hyperinsulinemia? hMG Insulin sensitizer uFSH GnRH-analogs HP-FSH rec-FSH

A. Medical Treatment  Infertility is treated by increasing the rate of ovulation, in part by reducing insulin drive through exercise and weight loss.  Ovarian stimulation is used for those patients who do not ovulate, despite loosing weight by different drugs and different protocols.

Medical Treatment (cont.)  Treat Hyperprolactinaemia with Bromocriptine.  Glucocorticoids for adrenal hyperplasia. ( 0.25mg Dexamethasone at night )  COC pills or POP for dysfunctional uterine bleeding and to reduce the risk of endometrial carcinoma.

B. Surgical treatment modalities Surgical Treatment Cauterization Wedge resection ( laser, electric )

Methods of Ovarian Surgery For Ovulation Induction In PCOS  Laparoscopic Techniques of Ovarian Surgery (LOS) Laparoscopic Ovarian Drilling (LOD) : Diathermy / LASER.  Transvaginal Techniques of Ovarian Surgery (TVOS) 1) Transvaginal mini-laparoscopy (Fertiloscopy) 2) Transvaginal ultrasound (TVS)-guided ovarian drilling.

LASER versus electrocautery for LOS: Electrocautery IS superior why ? 1) Less coast &easy application. 2) Achieve higher ovulation and pregnancy rate. 3) Less surface injury than CO2 LASER → Surface adhesion. 4) Effect of diathermy may last longer than the effect of LASER.

1) lifestyle modifications :  Weight loss  Caffeine intake  Alcohol consumption  Smoking  Dietary modification  Exercise  Psychosocial stressors

Role of weight loss in PCOS treatment: Reduce insulin resistance by about 50% Restore ovulation Regulate menstrual cycles Reduce pregnancy complications Improve fertility Improve health during pregnancy Improve the health of a child during pregnancy Improve emotional health (self-esteem, anxiety, depression) Reduce risk factors for diabetes and heart disease

PROTOCOLS OF MANAGEMENT IN ADOLESCENTS  Counselling for weight reduction and life style modification.  Carbohydrate and fat restricted diet.  Diet restriction and exercise is the sheet anchor of treatment for overweight.  Low glycemic index diet upto 85% will improve menstrual cycle regularity and ovulation in about six months

 Even 7% weight reduction may lead to spontaneous resumption of menses.  Moderate physical activity, minutes per day should be goal of all patient with adolescent PCOS.M.O.A:-  lowers circulating free androgen and insulin levels.  Increases SHBG, thereby decreases level of free testosterone.

FSH Ovulation Induction Protocol Increase dose slowly - can be very sensitive 25-50iu/day Increase dose by 50% Increase dose by 50% Starting dose Scan d14 Scan d7 Scan d21 hCG 5000u Follicle =16mm

2) Gonadotrophins :  Ovulation induction with gonadotrophins has been used as a second line treatment for CC-resistant PCOS women.  Disadvantage : expensive/ requires extensive monitoring /risk for OHSS & multiple pregnancy.  The high sensitivity of the PCOS to gonadotrophic stimulation is: they contain twice the number of FSH -sensitive antral follicles than the normal ovary.  A lowdose,step-up gonadotrophin therapy should be preferred.

 Recommended approach is : begin with a low dose of gonadotrophin, (typically 37.5– 75 IU/day) increasing after 7 days or more if no follicle >10 mm has yet emerged, in small increments, at intervals, until evidence of progressive follicular development is observed.  The maximum required daily dose of FSH/hMG seldom exceeds 225 IU/day.  There is no evidence of a difference between recombinant FSH (rFSH) and uFSH for ovulation induction in CC- resistant PCOS women.

3) 3) Laparoscopic Ovarian Drilling  WHO BENEFITS FROMMechanism LEOS ?Removalresistant, CC androgen-producing tissueProblems Slim, Anovulatory, Hazards of laparoscopic surgery & GA (although rare) raised S.LH TemporaryEfficacy <50% clomiphene-resistant women conceive (ovulation rate 80%+) Hormone profile returns to normal ?Fewer miscarriages compared to gonadotrophin injection treatment

3) Laparoscopic Ovarian Drilling (LOD):  Being as effective as gonadotrophin treatment and is not associated with an increased risk of multiple pregnancy or OHSS.  When applied properly, does not seem to compromise the ovarian reserve in PCOS women.  n economic evaluation has shown that the cost of a live birth after LOD is approximately one-third lower than the equivalent cost of gonadotrophin treatment.  Four punctures per ovary using a power setting of 30 W applied for 5s per puncture.

 Unilateral LOD being equally efficacious as bilateral drilling in inducing ovulation and achieving pregnancy in CC resistant PCOS patients and may be regarded as a suitable option with the potential advantage of decreasing the chances of adhesion formation.  Mechanism :  LOD drains the ovarian follicles containing a high concentration of androgens and inhibin reduction of blood androgens and blood inhibin resulting in an increase of FSH and recovery of the ovulation function.

 poor responders to LOD : - Women with marked obesity (BMI >35 kg/m2) - Marked hyperandrogenism (serum testosterone concentration >4.5 nmol/l - free androgen index (FAI) >15 - long duration of infertility (>3 years)  Predictor of higher probability of pregnancy : LH levels >10 IU/l in LOD responders

Technique of Laparoscopic Ovarian Drilling

4) Insulin-sensitizing drugs :

IMPROVEMENT OF HYPERINSULINEMIA BY INSULIN SENSITIZERS  Directly sensitizing insulin receptors.  Preventing neoglucogenesis.  Reducing absorption of glucose from intestine.  Increasing hepatic synthesis of SHBG level thereby reducing the level of bioactive free testosterone

Metformin  Decreases basal hepatic glucose output in patients and lowers fasting plasma glucose concentration.  It increases the uptake and oxidation of glucose by adipose tissue as well as lipogenesis.  S/E- diarrhoea, nausea, vomiting,specially initially. To avoid them metformin should be taken with meals and the dose increased gradually. Or SR release formulations are used once a day 1000 mg SR or 500mg SR twice a day

OTHER DRUGS WHICH CAN BE USED Rosiglitazone, Pioglitazone, D chiro inositol, Myoinositol N acetyl cysteine. Micronutrients

OTHER DRUGS WHICH CAN BE USED IN ADDITION TO O.C.P  In cases of failure or where there is clinical or biochemical evidence of gross hyperandrogenicity or hyperinsulinemia, addition of metformin is recommended.  Spironolactone- it has antiandrogenic effects in doses mg daily.  Finasteride - a competitive inhibitor of Type-2 5a reductase to treat hirsutism. Dose 1-5 mg/day.

5) Third-generation aromatase inhibitors : Anastrozole, Letrozole, Exemestane

DURING PREGNANCY  RECURRENT MISCARRIAGES 50%  GESTATIONAL DIABETES  PREGNANCY INDUCED HYPERTENSION  INTRAUTERINE GROWTH RETARDATION

6) Oral contraceptives : Oral contraceptive administration reduce serum LH, estradiol and androgen levels improving the ovarian microenvironment Inhance ovarian response to CC

7) N-acetyl-cysteine :  N-acetyl cysteine (NAC) is the acetylated variant of the amino acid L-cysteine.  It is an excellent source of sulfhydryl groups and is converted in vivo into metabolites that stimulate glutathione production, promote detoxification, and act directly as free-radical scavengers.  combination of CC and NAC increases ovulation and pregnancy rates in CC-resistant PCOS patients who also suffer from infertility.  NAC has antiapoptotic effects on the ovary and apoptosis is definitely responsible for the process of follicular atresia.

Biological activities of N-acetyl cysteine

8) Dexamethasone therapy : Dexamethasone (after 2 weeks of treatment ) Reduced DHEAS Reduced Testostrone Reduced LH levels and the LH/FSH ratio Inhance ovarian invironment

9) Bromocriptine : Bromocriptine administration provided no benefit in CC-resistant PCOS patients with normal prolactin levels. Bromocriptine administration improve ovarian response in hyperprolactinemic patients. Dopaminergic components have control of LH release in PCOS patients

10) IVF/ET or IVM :  If all else fails for the infertile PCOS patient then in-vitro fertilization is a last resort providing excellent results.

33-50% OF PATIENTS REFERRED FOR IVF HAVE PCOS

MANAGEMENT  life style and exercises  diet  insulin sensitisers  ocp’s  progesterone for bleed  statins/diabetes /antihypertensives if needed  omega 3 and micronutrients(inositol or myoinositol or n-actyl cysteine or alternative medicines

Algorithm for ovulation induction treatment in anovulatory infertile women with CC-resistant PCOS